Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: Shandong Cancer Hospital and Institute
Condition: Endometrial Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis
NCT06532539
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.